Demi-fine Jewelry Market to Penetrate Untapped Regions During 2022 to 2030: Grand View Research Inc.

 Demi-fine Jewelry Market Growth & Trends

The global demi-fine jewelry market size is expected to reach USD 6.6 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 14.8% from 2022 to 2030. The rising inclination of females for minimalistic yet elegant jewelry pieces for daily use or office wear is likely to drive the market. Moreover, its uniqueness and variety of options at affordable price drives the growth of the market. However, increasing e-commerce frauds along with a lack of information about the hallmarks of demi-fine jewelry are anticipated to hamper the market growth. The market is likely to develop at a prolific rate due to the modern, trend-led designs and affordable prices. The developing e-commerce sector, swelling presence of brands online, and rising usage of social media and apps are expected to create an ample growth opportunity for the market over the forecast period.

Demi-fine jewelry brands combine the fine and costume jewelry types by crafting pieces manufactured with gold and silver or plated pieces paired with semi-precious stones. Demi-fine jewelry brands are continuously developing and changing, so there's always something new to discover. Brands are constantly introducing new pieces, so there's always some reasonable trendy demi-fine jewelry to add to customers’ jewelry assortments without the high price tags related to high-end jewelry.

Demi-fine Jewelry Market Report Scope

Report Attribute	Details
Market size value in 2022	USD 2,100.1 million
Revenue forecast in 2030	USD 6.6 billion
Growth rate	CAGR of 14.8% from 2022 to 2030
Base year for estimation	2021
Historical data	2017 - 2020
Forecast period	2022 - 2030

The online segment is likely to dominate over the forecast period from 2022 to 2030. Most physical jewelry shops have an inadequate array of jewelry products. They can only hold so many items, and there are often several policies affecting the accessibility of jewelry. Online buying permits customers to find a variety of jewelry which are not available in a physical store. Moreover, customers are expecting great online jewelry options as well as a satisfying shopping experience. Customers are demanding various choices, a good online experience, easy payment options, and an easy return policy. The growth of this industry will have to keep up with consumer preferences as they demand more comfort and easiness in buying jewelry products online.

Asia Pacific acquired the largest revenue share in the demi-fine jewelry market in 2021. China was the major country in the region in terms of market share in 2021. This is attributed to the considerable development of small and medium-sized jewelers on the mainland in recent years. Apart from that, in several countries such as India, Japan, and South Korea demi-fine jewelry brands have been developing in leaps and bounds and have been making a foray into second and third-tier cities. Thus, Asia Pacific generated the largest revenue in 2021.

The market players face solid competition among each other, as some of them work at several locations and have a loyal customer base. In addition, key players are concentrating on building customer relationships through a customer service network. The companies working in the demi-fine jewelry market are expanding internationally to grab most of the demand and launching new designs through continual innovation is likely to push the market growth uphill.

Request a free sample copy or view report summary: Demi-fine Jewelry Market Report

Demi-fine Jewelry Market Report Highlights

• Europe is expected to dominate the market over the forecast period from 2022 to 2030. The growing number of affluent consumers in this region is also anticipated to increase the growth of the market over the forecast period
• Below 150 USD segment is likely to dominate over the forecast period from 2022 to 2030. The segment includes several demi-fine rings, neckpieces, and bracelets. The customers get several varieties of choices available in this price range
• Offline distribution channel segment generated the maximum revenue in 2021. This is attributed to the shopping advantages such as festive and seasonal offers, lower prices, discounted rates, and big displays with freedom of selection offered by the retail shops
• The women application segment is likely to dominate over the forecast period from 2022 to 2030. Various jewelry brands coming up with a different variety of demi-fine jewelry that is designed specifically for women consumers thus, the segment is expected to grow at the fastest CAGR over the forecast period 

Access Press Release@ https://www.grandviewresearch.com/press-release/global-demi-fine-jewelry-market

Demi-fine Jewelry Market Segmentation

Grand View Research has segmented the global demi-fine jewelry market on the basis of the price range, distribution channel, application, and region:

Demi-fine Jewelry Price Range Outlook (Revenue, USD Million, 2017 - 2030)

• Below 150 USD
• 151-300 USD
• 301-500 USD

Demi-fine Jewelry Distribution Channel Outlook (Revenue, USD Million, 2017 - 2030)

• Offline
• Online

Demi-fine Jewelry Application Outlook (Revenue, USD Million, 2017 - 2030)

• Women
• Men

Demi-fine Jewelry Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK.
  • Germany
  • France
  • Italy
• Asia Pacific
  • China
  • India
  • Japan
• Central & South America
  • Brazil
• Middle East & Africa
  • Turkey

List of Key Players in the Demi-fine Jewelry Market

• Otiumberg Limited
• Missoma Limited
• Edge of Ember
• Catbird
• Astley Clarke Limited
• WWAKE, Inc.
• Loren Stewart
• Monica Vinader Ltd.
• Natasha Schweitzer
• Sarah & Sebastian Pty Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Cell Culture Media Market Poised to Expand at a Robust Pace Over 2030: Grand View Research Inc.

 Cell Culture Media Market Growth & Trends

The global cell culture media market size is expected to reach USD 10,186.6 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.23% from 2023 to 2030. Expansion of biosimilars and biologics, growth in stem cell research, and emerging bio manufacturing technologies for cell-based vaccines are the major factors which are likely to drive the market. For instance, in October 2021, the Australian Government funded the Australian-led stem cell research through USD 25 million in grants.

The expansion of clear, regulatory approval paths for biosimilars in emerging markets is generating great opportunities for biosimilar monoclonal antibodies.  The availability of an approval pathway in the U.S., has led to new opportunities for bio manufacturers to enter major markets around the globe. Biosimilar versions of monoclonal antibodies have the probability to offer cost reductions of 25-30%, and many emerging market countries are vigorously developing pathways for approvals and are swiftly catching up. As this industry is expanding the key biopharmaceutical players are adopting robust culturing technologies to meet the increasing demand; thereby driving the growth of the market.

Cell Culture Media Market Report Scope

Report Attribute	Details
Market size value in 2023	USD 4,541.6 million
Revenue forecast in 2030	USD 10,186.6 million
Growth rate	CAGR of 12.23% from 2023 to 2030
Base year for estimation	2022
Historical data	2018 - 2021
Forecast period	2023 - 2030

Moreover, there is growing interest in improving the stem cell culture, because this technology is being used extensively in research for studying the stem cell biology, as well as for therapeutic applications. Furthermore, funding related to this research field has augmented in recent years which has accelerated the growth of the market. In addition to this, key media manufacturers launched new products for stem cell research. For instance, in September 2021, Bio-Techne Corporation launched a novel medium for the maintenance and expansion of induced pluripotent stem cells having applications in both translational and research workflows.

The outbreak of COVID-19 pandemic has improved the demand for well-established cell-based vaccine production technologies. Moreover, it has given rise to a few scientific innovations, particularly in the production and testing of vaccine technology. For instance, the Vero line originated from the African green monkey kidney and has been extensively used for viral vaccine manufacturing. It has also been used for the development of various SARS-CoV variants. ProVeroTM1 Serum-free Medium is one such medium manufactured by Lonza Bioscience which is protein-free, and of non-animal origin designed to support the growth of Vero cells and MDCK.

Moreover, in many European countries, cell-based flu vaccines have been approved. A probable advantage of cell culture technology is that it authorizes faster start-up of the manufacturing of vaccines during the pandemic. Today, the development of superior biological models, the optimization of culture growth medium, and the reduced dependence on animal-derived components endure to drive the rapidly developing vaccine development.

On the other hand, ethical issues concerning the use of animal-derived products hinders the industry growth. For instance, FBS is collected from the blood of fetal calves is one of the major ethical issues of serum containing media. It is projected that 600,000 liters of FBS is achieved from up to 1.8 million bovine fetuses are produced globally every year, presenting momentous scientific and ethical challenges. To overcome this issue, numerous workshops were held in the past on the replacement of fetal bovine serum and possible ways to reduce the use of FBS in media.

Request a free sample copy or view report summary: Cell Culture Media Market Report

Cell Culture Media Market Report Highlights

• By product, the serum-free media segment held the largest revenue share of the market. This is attributed to the increasing gene and cell therapy research along with advantages offered by SFM, which in turn is likely to increase the adoption and anticipate market growth
• The biopharmaceutical production segment is expected to grow lucratively over the forecast period. Strategic activities by key biopharmaceutical companies, increasing R&D, demand for more reproducible and better-defined media and growing biosimilars market drives the segment growth
• By type, the liquid media segment held the largest revenue share of the market in 2022. This is attributed to increasing number of biopharmaceutical manufacturers, both downstream and upstream, are switching from premixed powders to liquid media and hence, propelling market growth
• By end-user, the pharma and biopharma companies segment held a larger share in 2022, owing to the expansion of the current manufacturing capacities coupled with increasing prevalence of chronic disease which in turn demands for novel therapeutic drugs
• North America dominated the market in 2022 due to the growth in the pharmaceutical and biotechnology industry, presence of high R&D investment, and the development of novel culture media products in the region
• In Asia Pacific, the market is expected to grow considerably in the future owing to the flourishing biosimilar medicine industry along with increasing investments by major market players to increase their presence in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-cell-culture-media-market

Cell Culture Media Market Segmentation

Grand View Research has segmented the global cell culture media market based on product, application, type, end-user, and region:

Cell Culture Media Product Outlook (Revenue, USD Million, 2018 - 2030)

• Serum-free Media
  • CHO Media      
  • BHK Medium 
  • Vero Medium 
  • HEK 293 Media           
  • Other Serum-free media
• Classical Media
• Stem Cell Culture Media
• Specialty Media
• Chemically Defined Media
• Other Cell Culture Media

Cell Culture Media Application Outlook (Revenue, USD Million, 2018 - 2030)

• Biopharmaceutical Production
  • Monoclonal Antibodies
  • Vaccines Production
  • Other Therapeutic Proteins
• Diagnostics
• Drug Screening And Development
• Tissue Engineering And Regenerative Medicine
  • Cell And Gene Therapy
  • Other Tissue Engineering And Regenerative Medicine Applications
• Other Applications

Cell Culture Media Type Outlook (Revenue, USD Million, 2018 - 2030)

• Liquid Media  
• Semi-solid And Solid Media

Cell Culture Media End-user Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical And Biotechnology Companies
• Hospitals And Diagnostic Laboratories
• Research And Academic Institutes
• Other End-users

Cell Culture Media Regional Scope Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players of Cell Culture Media Market

• Thermo Fisher Scientific Inc.
• Merck KGaA
• CYTIVA
• Sartorius AG
• FUJIFILM Irvine Scientific, Inc.
• Lonza Group AG
• InvivoGen 
• STEMCELL Technologies Inc.
• PromoCell GmbH
• Cell Biologics, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Energy Ingredients Market Get Facts About Business Strategies 2022 to 2030: Grand View Research Inc.

 Energy Ingredients Market Growth & Trends

The global energy ingredients market size is expected to reach USD 36.79 billion by 2030, expanding at a CAGR of 7.4% from 2022 to 2030, according to a new report by Grand View Research, Inc. Increasing consumption of energy-enhancing products and growing health consciousness are some of the factors anticipated to drive the market during the forecast period. For instance, in April 2020, Taisho Pharmaceutical Holdings released Japan's first caffeine-free energy drink containing the botanical ingredient, enXtra. The product helps improve alertness and focus for up to five hours with or without caffeine. Furthermore, energy ingredients promote enhanced mental as well as physical health. Such factors will also aid in market growth.

In addition, increased consumer interest in snacks that are high in fiber, minimally processed, and contain energy-based ingredients will bode well with the growth of the market. According to an article published in Molecular Diversity Preservation International (MDPI), in January 2021, energy drink consumption increased steadily in young adults from 0.5% to 5.5% in France. Also, the rising popularity of products with various cognitive health benefits will boost the growth of the market in the forecast period considered.

Energy Ingredients Market Report Scope

Report Attribute	Details
Market size value in 2022	USD 20.92 billion
Revenue forecast in 2030	USD 36.79 billion
Growth Rate	CAGR of 7.4% from 2022 to 2030
Base year for estimation	2021
Historical data	2017 - 2020
Forecast period	2022 - 2030

Caffeine was the largest segment in 2021 and is expected to maintain its dominance during the forecast period. The consumption of healthier beverages, including caffeinated energy & sports drinks, is witnessing substantial year-on-year growth. The consumption of energy drinks by the U.S. population has increased over the years. On the other hand, the demand for carbonated drinks has been decreasing as their consumption increases the risk of cancer and causes other health ailments. According to a report published by the Association of Military Surgeons of the United States in 2021, approximately 75% of deployed U.S. military personnel consume energy beverages/drinks. Out of the 627 surveyed soldiers, 29.2% of respondents reported at least daily use, and 16.1% drank more than two energy drinks per day.

The taurine segment was valued as the second fastest-growing segment in 2021. Functional foods are enriched with energy ingredients such as antioxidants, caffeine, ginseng, taurine, and fatty acids to provide a positive effect on human health beyond the intake of essential nutrition. Manufacturers in the market are launching energy drinks and beverages with the aforementioned ingredients. For instance, in October 2021, Belgium-headquartered AB InBev, the world’s largest brewer, launched the Budweiser Beats energy drink in India, made with natural caffeine, B-vitamins (B3, B5, B6, B12), and taurine.

The energy ingredients industry is fragmented in nature, with a major share almost equally divided among key players of the market such as BASF SE; Spectrum Chemical Mfg. Corp.; RFI Ingredients; Korea Ginseng Corporation; Orkla; ILHWA CO., LTD.; Applied Food Sciences, Inc. (AFS); Naturalin Bio-Resources Co., Ltd.; Changsha Huir Biological-Tech Co., Ltd.; Sinochem Pharmaceutical Co., Ltd.; KOEI KOGYO CO., LTD; and Aarti Industries Ltd.

Request a free sample copy or view report summary: Energy Ingredients Market Report

Energy Ingredients Market Report Highlights

• Asia Pacific is expected to contribute a majority of the revenue share to become the largest segment in 2021 owing to the rising consumer awareness regarding lifestyle disorders and the resultants’ shift toward healthier alternatives
• The creatine segment is projected to register the fastest growth during the forecast period as these ingredients boost energy and power for a "quick burst"
• The beverage is predicted to become a faster-growing segment during the forecast period owing to the growing popularity of energy drinks

Access Press Release@ https://www.grandviewresearch.com/press-release/global-energy-ingredients-market

Energy Ingredients Market Segmentation

Grand View Research has segmented the global energy ingredients market based on product, application, and region:

Energy Ingredients Product Outlook (Volume, Metric Tons; Revenue, USD Million, 2017 - 2030)

• Caffeine
• Creatine
• Taurine
• Ginseng
• Others

Energy Ingredients Application Outlook (Volume, Metric Tons; Revenue, USD Million, 2017 - 2030)

• Food
• Beverage
• Supplements
• Others

Energy Ingredients Regional Outlook (Volume, Metric Tons; Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
  • Italy
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Central & South America
  • Brazil
• Middle East & Africa
  • South Africa

List of Key Players in the Energy Ingredients Market

• BASF SE
• Spectrum Chemical Mfg. Corp.
• RFI Ingredients
• Korea Ginseng Corporation
• Orkla
• ILHWA CO., LTD.
• Applied Food Sciences, Inc. (AFS)
• Naturalin Bio-Resources Co., Ltd.
• Changsha Huir Biological-Tech Co., Ltd.
• Sinochem Pharmaceutical Co., Ltd.
• KOEI KOGYO CO., LTD
• Aarti Industries Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

North America In Vitro Diagnostics Market Outlook Growth Emerging Factors On Geography, Technological Advancements And Mounting Demand Forecast To 2030

 North America In Vitro Diagnostics Market Growth & Trends

The North America in vitro diagnostics market size is expected to reach USD 39.67 billion by 2030 and is expected to decline at 2.89% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. On the other hand, the market is also expected to cater to various growth opportunities in key segments. For example, the development of automated in vitro diagnostic solutions for hospitals and laboratories to provide accurate, efficient, and error-free diagnosis is anticipated to drive market growth in the coming years. In addition, rising efforts to develop POC solutions and the surge in adoption of POC tests across different medical diagnostic applications, including infectious diseases, pregnancy, cancer, and others, are fueling the market growth.

The market growth is likely to be fueled by rising efforts from leading participants to develop fast and accurate products that allow easy-to-use, advanced, and flexible testing options. For instance, in August 2022, DxGen Corp. and Precision Diabetes, Inc. announced an agreement to develop and launch a fully automatic POC analyzer in the U.S. market to measure a complete profile of diabetes tests. The analyzer is capable to test C-reactive protein, urine analysis, A1C levels, and other diabetes confirmatory tests at POC facilities.

North America In Vitro Diagnostics Market Report Scope

Report Attribute	Details
Market size value in 2023	USD 48.19 billion
Revenue forecast in 2030	USD 39.67 billion
Growth rate	CAGR of -2.89% from 2023 to 2030
Base year for estimation	2022
Historical data	2018 - 2021
Forecast period	2023 - 2030

Furthermore, in November 2021, Lumos Diagnostics, a key player in POC diagnostics, announced that its Lumos CoviDx SARS-CoV-2 Rapid Antigen Test received an interim order authorization from Health Canada. This test offers easy-to-interpret outcomes in just 15-20 minutes in serial testing of asymptomatic patients. The easy availability of point-of-care tests in home care settings, community pharmacies, retail health clinics, urgent care centers, intensive care units, and operating rooms is fueling the adoption of POC IVD products across the region.

The North America in vitro diagnostics industry is gaining traction as diagnostic laboratories frequently employ fully automated tools. Moreover, automated devices are highly scalable, meet a high level of performance expectations, eliminate batch testing, and provide quick results to medical professionals. Leading participants are continuously working on building automated devices because of these benefits. For instance, in May 2022, BD launched a new, fully automated high-throughput infectious disease molecular diagnostics platform in the U.S. market.

Furthermore, the increasing incidence of target diseases, favorable government initiatives, and the flourishing healthcare sector in the region are anticipated to offer lucrative growth opportunities.

For instance, in November 2022, Hologic, Inc. was awarded a USD 19 million contract from BARDA to support its research and development activities. In addition, in January 2022, Aline, Inc. & Nectar Product Development announced a strategic partnership to improve POC in vitro diagnostic products.

Request a free sample copy or view report summary: North America In Vitro Diagnostics Market Report

North America In Vitro Diagnostics Market Report Highlights

• The reagents segment held the largest market share in 2022 owing to extensive R&D initiatives being undertaken by major market players for the development of novel test kits
• The molecular diagnostics segment accounted for the largest market share in 2022, thanks to rapid evolution in technology, increasing burden of target diseases, and surge in product launches by leading participants
• Based on application, the infectious disease segment dominated the market in terms of revenue share in 2022. On the other hand, the oncology segment is expected to be the fastest-growing segment over the forecast period
• The hospitals segment was the largest end-user in 2022, owing to the rising demand for affordable services, the surging trend for personalized treatments, and the presence of favorable reimbursement policies
• Canada is expected to exhibit the fastest growth over the forecast period in the region due to the increasing geriatric population, and large patient pool with a high prevalence of chronic diseases

Access Press Release@ https://www.grandviewresearch.com/press-release/north-america-in-vitro-diagnostics-market-analysis

North America In Vitro Diagnostics Market Segmentation

Grand View Research has segmented the North America in vitro diagnostics market based on product, technology, application, end-use, test location, and country:

North America In Vitro Diagnostics Product Outlook (Volume, Number of Tests and Instruments; Revenue, USD Million, 2018 - 2030)

• Instruments
  • End-use
    • Hospitals
    • Laboratories
    • Home Care
    • Clinic/Others
      • Physician Office
      • Pharmacy & Retail Clinics
      • Non-practice Clinics
      • Urgent Care Clinics
      • Others
    • Reagents
      • End-use
        • Hospitals
        • Laboratories
        • Home Care
        • Clinic/Others
          • Physician Office
          • Pharmacy & Retail Clinics
          • Non-practice Clinics
          • Urgent Care Clinics
          • Others
        • Services
          • End-use
            • Hospitals
            • Laboratories
            • Home Care
            • Clinic/Others
              • Physician Office
              • Pharmacy & Retail Clinics
              • Non-practice Clinics
              • Urgent Care Clinics
              • Others

North America In Vitro Diagnostics Technology Outlook (Volume, Number of Tests and Instruments; Revenue, USD Million, 2018 - 2030)

• Immunoassay
  • Product
    • Instruments
    • Reagents
    • Services
  • End-use
    • Hospitals
    • Laboratories
    • Home Care
    • Clinic/Others
      • Physician Office
      • Pharmacy & Retail Clinics
      • Non-practice Clinics
      • Urgent Care Clinics
      • Others
    • Hematology
      • Product
        • Instruments
        • Reagents
        • Services
      • End-use
        • Hospitals
        • Laboratories
        • Home Care
        • Clinic/Others
          • Physician Office
          • Pharmacy & Retail Clinics
          • Non-practice Clinics
          • Urgent Care Clinics
          • Others
        • Clinical Chemistry
          • Product
            • Instruments
            • Reagents
            • Services
          • End-use
            • Hospitals
            • Laboratories
            • Home Care
            • Clinic/Others
              • Physician Office
              • Pharmacy & Retail Clinics
              • Non-practice Clinics
              • Urgent Care Clinics
              • Others
            • Molecular Diagnostics
              • Product
                • Instruments
                • Reagents
                • Services
              • End-use
                • Hospitals
                • Laboratories
                • Home Care
                • Clinic/Others
                  • Physician Office
                  • Pharmacy & Retail Clinics
                  • Non-practice Clinics
                  • Urgent Care Clinics
                  • Others
                • Coagulation
                  • Product
                    • Instruments
                    • Reagents
                    • Services
                  • End-use
                    • Hospitals
                    • Laboratories
                    • Home Care
                    • Clinic/Others
                      • Physician Office
                      • Pharmacy & Retail Clinics
                      • Non-practice Clinics
                      • Urgent Care Clinics
                      • Others
                    • Microbiology
                      • Product
                        • Instruments
                        • Reagents
                        • Services
                      • End-use
                        • Hospitals
                        • Laboratories
                        • Home Care
                        • Clinic/Others
                          • Physician Office
                          • Pharmacy & Retail Clinics
                          • Non-practice Clinics
                          • Urgent Care Clinics
                          • Others
                        • Others
                          • Product
                            • Instruments
                            • Reagents
                            • Services
                          • End-use
                            • Hospitals
                            • Laboratories
                            • Home Care
                            • Clinic/Others
                              • Physician Office
                              • Pharmacy & Retail Clinics
                              • Non-practice Clinics
                              • Urgent Care Clinics
                              • Others

North America In Vitro Diagnostics Application Outlook (Volume, Number of Tests and Instruments; Revenue, USD Million, 2018 - 2030)

• Infectious Disease
  • Disease
    • Methicillin-resistant Staphylococcus Aureus (MRSA)
    • Clostridium Difficile
    • Vancomycin-resistant Enterococci (VRE)
    • Carbapenem-resistant Bacteria
    • Flu
    • Respiratory Syncytial Virus (RSV)
    • Candida
    • Tuberculosis and Drug-resistant TBA
    • Meningitis
    • Gastrointestinal Panel Testing
    • Chlamydia
    • Gonorrhea
    • HIV
    • Hepatitis C
    • Hepatitis B
    • Other Infectious Diseases
  • End-use
    • Hospitals
    • Laboratories
    • Home Care
    • Clinic/Others
      • Physician Office
      • Pharmacy & Retail Clinics
      • Non-practice Clinics
      • Urgent Care Clinics
      • Others
    • Diabetes
      • End-use
        • Hospitals
        • Laboratories
        • Home Care
        • Clinic/Others
          • Physician Office
          • Pharmacy & Retail Clinics
          • Non-practice Clinics
          • Urgent Care Clinics
          • Others
        • Oncology
          • Disease
            • Breast Cancer
            • Prostate Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Kidney Cancer
            • Liver Cancer
            • Blood Cancer
            • Lung Cancer
            • Other Cancer
          • End-Use
            • Hospitals
            • Laboratories
            • Home Care
            • Clinic/Others
              • Physician Office
              • Pharmacy & Retail Clinics
              • Non-practice Clinics
              • Urgent Care Clinics
              • Others
            • Cardiology
              • Disease
                • Coronary Heart Disease
                • Stroke
                • Peripheral Arterial Disease
                • Aortic Disease
                • Others
              • End-use
                • Hospitals
                • Laboratories
                • Home Care
                • Clinic/Others
                  • Physician Office
                  • Pharmacy & Retail Clinics
                  • Non-practice Clinics
                  • Urgent Care Clinics
                  • Others
                • Nephrology
                  • Disease
                    • UTI
                    • Kidney Disease
                    • Diabetes
                    • Others
                  • End-use
                    • Hospitals
                    • Laboratories
                    • Home Care
                    • Clinic/Others
                      • Physician Office
                      • Pharmacy & Retail Clinics
                      • Non-practice Clinics
                      • Urgent Care Clinics
                      • Others
                    • Autoimmune Diseases
                      • Disease
                        • Rheumatoid Arthritis
                        • Inflammatory Bowel Disease
                        • Osteoporosis
                        • Celiac Disease
                        • Fibromyalgia
                      • End-use
                        • Hospitals
                        • Laboratories
                        • Home Care
                        • Clinic/Others
                          • Physician Office
                          • Pharmacy & Retail Clinics
                          • Non-practice Clinics
                          • Urgent Care Clinics
                          • Others
                        • Drug Testing
                          • End-use
                            • Hospitals
                            • Laboratories
                            • Home Care
                            • Clinic/Others
                              • Physician Office
                              • Pharmacy & Retail Clinics
                              • Non-practice Clinics
                              • Urgent Care Clinics
                              • Others
                            • Others
                              • End-use
                                • Hospitals
                                • Laboratories
                                • Home Care
                                • Clinic/Others
                                  • Physician Office
                                  • Pharmacy & Retail Clinics
                                  • Non-practice Clinics
                                  • Urgent Care Clinics
                                  • Others

North America In Vitro Diagnostics End-use Outlook (Volume, Number of Tests and Instruments; Revenue, USD Million, 2018 - 2030)

• Hospitals
• Laboratories
• Home Care
• Clinic/Others
  • Physician Office
  • Pharmacy & Retail Clinics
  • Non-practice Clinics
  • Urgent Care Clinics
  • Others

North America In Vitro Diagnostics Test Location Outlook (Revenue, USD Million, 2018 - 2030)

• Point-of-Care
• Others

North America In Vitro Diagnostics Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada

List of Key Players in the North America In Vitro Diagnostics Market

• Abbott
• bioMérieux SA
• Bio-Rad Laboratories, Inc.
• BD
• Siemens Healthcare GmbH
• QIAGEN
• Quidel Corporation
• Hoffmann-La Roche Ltd
• Sysmex Corporation
• Charles River Laboratories International, Inc.
• Quest Diagnostics
• Agilent Technologies, Inc.
• Danaher

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global Demand for Dermatology CRO Market to Incur Considerable Upsurge During 2023– 2030: Grand View Research Inc.

 

Dermatology CRO Market Growth & Trends

The global dermatology CRO market size is expected to reach USD 8,057.9 million by 2030, registering a CAGR of 6.8% over the forecast period, according to a new report by Grand View Research, Inc. Rising influx of contract research organizations (CROs) to mitigate the disease burden associated with dermatological conditions is a key driver for this market. Moreover, the rising demand for topical dermatological medications, such as anti-infective, anti-inflammatory agents, local anesthetics, emollients, and cleansers, to cure acne are major factors driving the market growth. High demand for speedy diagnosis, an increase in the prevalence of skin cancer and other skin problems, and increased awareness regarding skin diseases are major factors boosting the market growth.

An increase in cases of skin disease across the globe is expected to propel the market growth in the forecast period. Atopic dermatitis is one of the most common inflammatory skin diseases, affecting around 5-10% of individuals in the U.S. Around one in three individuals in the country with atopic dermatitis have moderate-to-severe disease. Moreover, skin cancer is the most common cancer in the U.S. According to the American Academy of Dermatology, around 1 in 5 individuals would develop skin cancer in their lifetime. In addition, it is estimated that around 9500 individuals in the country are diagnosed with skin cancer every day. The COVID-19 pandemic significantly impacted the market.

Clinical trials in numerous therapeutic fields, including dermatology, were impacted by the COVID-19 pandemic. Several clinical trials were temporarily delayed or halted, impacting the timelines and progress of research studies. This disruption is expected to affect the growth and revenue of dermatology CROs, as their services are closely tied to clinical trial activities. Furthermore, patent expiration in the dermatology industry and growing investment in R&D programs are key factors anticipated to drive market growth in the coming years. For instance, in February 2022, Recipharm acquired CDMO Arranta Bio to expand its mRNA biologics offerings in the U.S. This acquisition is expected to improve the company's capabilities in developing medications in the area of cancer, psoriasis, infectious diseases, and other diseases.

Request a free sample copy or view report summary: Dermatology CRO Market Report

Dermatology CRO Market Report Highlights

• Based on type, the clinical segment accounted for the largest revenue share of 76.10% in 2022. This is attributed to the globalization of clinical trials, technological advancements, and an increase in demand for dermatology CROs to conduct clinical trials
• Based on service type, the regulatory/medical affairs segment is expected to show a significant market share in the forecast period. Increasing demand to obtain approval for new products and differences in drug regulations globally are some of the major factors driving the segment growth
• Asia Pacific captured the largest revenue share of over 43.29% in 2022. This is due to the diversity in population, high prevalence of skin disorders, improving regulatory framework, and, the ease with which patients may be recruited and retained
• A post-covid surge in clinical trials provided a lucrative opportunity for CROs to enter the dermatology space. For instance, in January 2022, Vial started providing dermatology outsourcing services via its arm Vial Dermatology CRO. Wherein, they partnered with 35 dermatology clinics in the U.S. to provide faster clinical trials

Access Press Release@ https://www.grandviewresearch.com/press-release/global-dermatology-cro-market

Dermatology CRO Market Segmentation

Grand View Research has segmented the global dermatology CRO market based on type, service type, and region:

Dermatology CRO Type Outlook (Revenue, USD Million, 2018 - 2030)

• Drug Discovery
  • Target Validation
  • Lead Identification
  • Lead optimization
• Preclinical
• Clinical
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Dermatology CRO Service Outlook (Revenue, USD Million, 2018 - 2030)

• Project Management/Clinical Supply Management
• Data Management
• Regulatory/Medical Affairs
• Medical Writing
• Clinical Monitoring
• Quality Management/Assurance
• Bio-statistics
• Investigator Payments
• Laboratory
• Patient and Site Recruitment
• Technology
• Others

Dermatology CRO Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Iran
  • Kuwait

List of Key Players of Dermatology CRO Market

• IQVIA HOLDINGS INC.
• Covance Inc.
• Pharmaceutical Product Development, LLC (PPD)
• Parexel International Corporation
• Charles River Laboratories International, Inc.
• Icon, Plc
• Syneos Health
• Wuxi AppTec
• Bioskin
• Proinnovera

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

North America Packaged Salad Market to Reflect Robust Expansion During 2021-2028: Grand View Research Inc.

 North America Packaged Salad Market Growth & Trends

The North America packaged salad market size is expected to reach USD 10.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.8% from 2021 to 2028. Rising health consciousness among consumers and a growing inclination toward convenience foods are expected to be the major factors contributing to the growth of the market.

The branded category segment led the market in 2020. Branded packaged salads are salads that are widely available nationally or internationally and are not limited to one retailer or region. Retail channels usually trade both branded and private label packaged salads to take advantage of exclusive products.

Vegetarian products are most popular among customers and the demand for vegetarian packaged salads is being pushed by the rising number of health-conscious consumers in North America. Individuals searching for organic produce/products continue to create a large demand for vegetarian packed salads in this regard.

The U.S. dominated the North American market in 2020. With the increasing awareness about leading a healthy lifestyle, the demand for packaged salads has been growing significantly among consumers. Furthermore, the high penetration of key market players in the U.S. has improved product accessibility across the country.

The market players face stiff competition from each other as some of them are among the top frozen bakery manufacturers and have a large customer base. The market is fragmented with the presence of a large number of global and regional players such as Earthbound Farm; Vegpro International Inc.; Dole Food Company, Inc.; and Fresh Express Incorporated.

Request a free sample copy or view report summary: North America Packaged Salad Market Report

North America Packaged Salad Market Report Highlights

• Canada is projected to register the fastest growth rate of 9.2% from 2021 to 2028 due to increasing awareness regarding the health benefits of eating salads as a part of the daily diet
• By type, packaged kits are expected to expand at the fastest CAGR of 8.0% from 2021 to 2028 due to the growing consumption of healthy meal alternative products that are healthy and contain less fat
• The offline distribution channel held the largest share of over 80.0% in 2020as supermarkets offer significant advantages to consumers, such as the freedom of selection, lower prices, and the high visibility of international brands

Access Press Release@ https://www.grandviewresearch.com/press-release/north-america-packaged-salad-market-analysis

North America Packaged Salad Market Segmentation

Grand View Research has segmented the North America packaged salad market on the basis of category, product, processing, type, distribution channel, and country:

North America Packaged Salad Category Outlook (Revenue, USD Million, 2016 - 2028)

• Branded
• In-store/Private Label

North America Packaged Salad Product Outlook (Revenue, USD Million, 2016 - 2028)

• Vegetarian
• Non-vegetarian

North America Packaged Salad Processing Outlook (Revenue, USD Million, 2016 - 2028)

• Organic
• Conventional

North America Packaged Salad Type Outlook (Revenue, USD Million, 2016 - 2028)

• Packaged Greens
• Packaged Kits

North America Packaged Salad Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

• Online
• Offline

North America Packaged Salad Country Outlook (Revenue, USD Million, 2016 - 2028)

• US.
  • Florida
  • New York
  • Pennsylvania
  • Illinois
  • Ohio
  • Georgia
• Canada
  • Quebec
  • British Colombia
  • Ontario
  • Alberta
  • Rest of Canada

List of Key Players of North America Packaged Salad Market

• Earthbound Farm
• Vegpro International Inc.
• Dole Food Company, Inc.
• Fresh Express Incorporated
• BrightFarms
• Eat Smart
• Misionero
• Gotham Greens Holdings, LLC
• Mann Packing Co.
• Bonduelle

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Automotive Powertrain Market Soaring Demand Assures Motivated Revenue Share By 2025

 Automotive Powertrain Market Growth & Trends

The global automotive powertrain market size is expected to reach USD 1,125.66 billion by 2025, according to a new report by Grand View Research, Inc. The market is anticipated to register a CAGR of 11.6% from 2021 to 2025. The increasing demand for environment-friendly vehicles and increasingly stringent government regulations regarding vehicular emission are expected to favor the demand for automotive powertrains in the market. Moreover, technological advancements in powertrain systems to enhance the vehicle's efficiency are anticipated to boost market growth prospects over the forecast period.

The adoption rate and pace of evolution of automotive powertrain vary across regions according to purchase subsidies, regulatory differences, road pricing, fuel taxation policy, state support, and consumer preferences. In Europe and countries such as China, South Korea, and Japan, stringent regulations are expected to make OEMs shift their focus on electrified powertrain options. Other significant factors that constitute the evolution of powertrain include developing charging infrastructure in different regions globally.

Automotive Powertrain Market Report Scope

Report Attribute	Details
Market size value in 2021	USD 725.45 billion
Revenue forecast in 2025	USD 1,125.66 billion
Growth Rate	CAGR of 11.6% from 2021 to 2025
Base year for estimation	2020
Historical data	2015 - 2019
Forecast period	2021 - 2025

Increasing vehicle sales and the growing adoption of automated transmission vehicles in emerging countries such as India, China, Indonesia, Japan, and Brazil, are expected to drive the market. The substantial rise in the purchasing power of consumers has increased the demand for state-of-the-art motor vehicles, driving the demand for upgraded systems. The rising use of All Wheel Drive in SUVs in emerging regions is also expected to support the growth of the powertrain market. The growing demand for AWD-equipped vehicles in the Asia Pacific region is expected to boost the growth of the all-wheel-drive system market.

The COVID-19 pandemic has hampered the growth prospects of several industries in 2020; powertrain manufacturers are facing a year-on-year decline in unit volumes sales and revenues. For instance, BorgWarner Inc., a prominent market player in the electric powertrain market, witnessed a decrease in the e-Propulsion & Drivetrain business segment. However, the demand for vehicles with upgraded safety features is likely to increase post-pandemic. Since automotive powertrain plays a vital role in automobiles, the market could regain momentum. Furthermore, despite the pandemic, the growing demand for electric vehicles is anticipated to boost the demand for automotive powertrains.

Request a free sample copy or view report summary: Automotive Powertrain Market Report

Automotive Powertrain Market Report Highlights

• In terms of vehicle type, the commercial vehiclesegment is expected to expand at the highest CAGR of around 11.7% over the forecast period. This can be attributed to the increasing demand for a unified supply chain network connecting multiple transportation modes, including freight rail, air, and express delivery services, maritime transport, and truck transport
• In terms of propulsion type, the ICE segment dominated the market in 2020 and is anticipated to value at more than USD 902.91 billion by 2028. This can be attributed to the price difference between ICEs and EVs and inadequate charging infrastructure
• The Asia Pacific regional market held the dominant market share in 2020, with the China market being a significant contributor. China remains the largest manufacturer of automobiles and automotive markets across the globe. In 2020, China ranked first in terms of the production of passenger cars globally, which stood at nearly 21 million

Access Press Release@ https://www.grandviewresearch.com/press-release/global-automotive-powertrain-market

Automotive Powertrain Market Segmentation

Grand View Research has segmented the global automotive powertrain market based on vehicle type, propulsion type, and region:

Automotive Powertrain Vehicle Type Outlook (Volume, Thousand Units; Revenue, USD Billion, 2015 - 2025)

• Passenger Vehicle
• Commercial Vehicle

Automotive Powertrain Propulsion Type Outlook (Volume, Thousand Units; Revenue, USD Billion, 2015 - 2025)

• ICE
  • Gasoline
  • Diesel
  • Natural Gas Vehicle
• BEV
  • PHEV
  • Electric Vehicle

Automotive Powertrain Regional Outlook (Volume, Thousand Units; Revenue, USD Billion, 2015 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • Greater China
  • Japan
  • India
  • South Korea
• Latin America
• Middle East & Africa

List of Key Players in the Automotive Powertrain Market

• BorgWarner
• Continental AG
• Magna International Inc.
• Marelli Holdings Co., Ltd.
• Mitsubishi Electric Corp
• Nidec Corporation
• Robert Bosch GmbH
• Schaeffler AG
• Valeo
• ZF Friedrichshafen AG

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Dry-cleaning And Laundry Services Market Witness Excellent Revenue Growth During 2023-2030: Grand View Research Inc

 Dry-cleaning And Laundry Services Market Growth & Trends

The global dry-cleaning and laundry services market size is estimated to reach USD 118.71 billion by 2030, registering a CAGR of 7.0% from 2023 to 2030, according to a new report by Grand View Research, Inc. The significance of having a clean and hygienic living environment is becoming more widely acknowledged. This is crucial for bedding products like duvets, which can harbor pollutants like dust mites and allergies. More consumers are turning to dry-clean and laundry services for better cleaning and sanitization of clothing and duvets.Modern consumers are increasingly preferring cashless payment options, which is having a significant impact on the laundry industry. As a result, many laundry providers and dry-cleaning services are shifting to card payment systems.

These systems offer added convenience to both business owners and customers by eliminating the need for change, while also improving safety and fostering customer loyalty. Furthermore, technological advancements have enabled machines to work in tandem with chemical, pump, ozone, and UV disinfection systems, which is especially beneficial during the COVID-19 pandemic.  With the growing concerns about high utility bills and the environment, energy efficiency has become increasingly important for investors and customers alike. Commercial laundry equipment has made significant strides in recent years, offering greater control and shorter dry times that reduce energy consumption and lower utility bills.

Dry-cleaning And Laundry Services Market Report Scope

Report Attribute	Details
Market size value in 2023	USD 73.55 billion
Revenue forecast in 2030	USD 118.71 billion
Growth rate	CAGR of 7.0% from 2023 to 2030
Base year for estimation	2022
Historical data	2017 - 2021
Forecast period	2023 - 2030

This has spurred many laundry facilities and dry-cleaning services to upgrade their equipment, not only to save money but also to attract more eco-conscious customers. The latest commercial laundry equipment is designed to be more energy-efficient than ever before. These machines use less water, have shorter dry times, and provide more controls to adjust levels and temperature, all of which help reduce energy consumption, lower utility bills, and make it easier to run an energy-efficient laundry facility. Many key players have started upgrading their commercial laundry equipment to improve energy efficiency and attract more environment-conscious customers.

By reducing fossil fuel usage, lowering greenhouse gas emissions, and conserving natural resources, energy-efficient laundry equipment is essential for businesses that want to reduce their environmental impact and save money on utility bills.Increasing adoption of online services by the overall consumer group has been a major trend in the industry and helping businesses grow. In addition, the convenience and effortlessness provided by such services is another aspect that is leading toward their high adoption. High disposable incomes and rising expenditure on personal hygiene are acting as major catalysts for laundry facilities and dry-cleaning services, influencing their acceptance in the U.S.

Subscription packages and offers are expected to further popularize these services among consumers. Many subscription-based laundry services use high-quality cleaning products and equipment to ensure that the laundry is cleaned thoroughly and effectively and to give consumers one less chore to complete in their day-to-day lives. Laundryheap is a subscription-based laundry service that operates in several major cities around the world, including London, Paris, and Dubai. Customers can schedule laundry pickups and deliveries through the Laundryheap app and can choose from a variety of services, including wash & fold, dry cleaning, and ironing.

Request a free sample copy or view report summary: Dry-cleaning And Laundry Services Market Report

Dry-cleaning And Laundry Services Market Report Highlights

• Asia Pacific dominated the global market in 2022. The market is anticipated to be driven by the presence of rapidly developing economies like India and China, a growing working population, and rising spending on cleaning services
• The commercial setting segment is estimated to register the fastestCAGR from 2023 to 2030. Commercial laundry services are increasingly adopting sustainable practices, such as using eco-friendly detergents and reducing water usage. This is particularly important for businesses that want to minimize their environmental impact
• To maintain market share, industry participants are broadening their service offerings. For instance, in March 2021, Alliance Laundry Systems LLC introduced a new generation of washers featuring touchscreen controls and full connectivity options for select Primus and IPSO models
• The touchscreen control platform offers exceptional versatility for laundry customers and also helps reduce touchpoints

Access Press Release@ https://www.grandviewresearch.com/press-release/global-dry-cleaning-laundry-services-market

Dry-cleaning And Laundry Services Market Segmentation

Grand View Research has segmented the global dry-cleaning and laundry services market on the basis of services, application, and region:

Dry-cleaning And Laundry Services Outlook (Revenue, USD Million, 2017 - 2030)

• Laundry
• Dry Cleaning
• Duvet Cleaning

Dry-cleaning And Laundry Services Application Outlook (Revenue, USD Million, 2017 - 2030)

• Residential
• Commercial

Dry-cleaning And Laundry Services Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • France
  • UK.
  • Spain
  • Italy
• Asia Pacific
  • China
  • India
  • Japan
• Central & South America
  • Brazil
• Middle East & Africa
  • South Africa

List of Key Players in Dry-cleaning And Laundry Services Market

• Alliance Laundry Systems LLC
• The Huntington Company
• ZIPS Dry Cleaners
• Alsco Pty Ltd.
• Rinse, Inc.
• Marberry Cleaners & Launderers, Inc.
• Tide Dry Cleaners (Procter & Gamble)
• City Dry Cleaning Company
• East Rand Cleaners
• Cleanly

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.